Good Things Come in Pairs – Tellgen Got Two New Certification of Autoimmune

0 Comments

It is an official! Tellgen received two NMPA registration certifications on autoimmune products showing the advanced planning in the research and development. The two new certificates of PLA2R (湘械注准20212401410) and Autoimmune Liver Disease Antibody Spectrum (湘械注准20212401578).

Autoimmune Liver Disease Antibody Spectrum Detection Kit

       Competitive Advantages of Tellgen

  • Quantitative Result: Digital Result of traceable variables and antibodies
  • Optimized Marker: The new AMA[M2-3E] has a better detection performance than the traditional AMA-M2.
  • Multiplexed Assay: Presenting 6 analytes at once with a high cost-efficiency.
  • Easy Operation: TESMI System, autoimmune assays all in one, on the spot testing, fully automated, high throughput.

Antimitochondrial antibodies M2-3E (AMA[M2-3E]) has a same specificity and a higher sensitivity than traditional analytes AMA-M2.

Antiphospholipid A2 Receptor Detection Kit

       Competitive Advantages of Tellgen

  • Quantitative Result: Digital Result of traceable variables
  • Easy Operation: TESMI System, autoimmune assays all in one, on the spot testing, fully automated, high throughput

Antiphospholipid A2 receptor antibody (anti-PLA2R antibody for short) detection kit is a good news for patients with membranous nephropathy, and a long-waited non-invasive serological test. Let’s look at the literature on the significance of this index research results.

Conclusion:

  • PLA2R has a sensitivity of 70%-80% and a specificity of 100% to primary membranous nephropathy patients.
  • PLA2R can occur up to a few months before proteinuria and disappear from weeks to months before renal remission.
  • Patient with higher antibody level require longer immunosuppressive therapy than patients with lower antibody level.

Flow fluorescence technology is the mainstream autoimmune diseases detection technology in the world, also the featured technology of Tellgen. TESMIF4000+FlowAI® detection platform introduced by Tellgen integrates the advantages of full automation, on-demand detection, quantification, and high throughput, and it frees up manpower, smaller sample requirement, produces more accurate and intuitive results, and shortens TAT time to 2 hours. Thus, it meets the clinical demand for and development trend of autoimmunity detection. In the future, there will be more product certification, please look forward to it.

Categories: